1.
Wirk B, Lim J. Ruxolitinib Is an Effective Therapy for Ciltacabtagene Autoleucel-Associated Parkinsonism in Multiple Myeloma. J Hematol. Published online April 22, 2025. doi:10.14740/jh2046